login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
QIAGEN N.V. (QGEN) Stock News
USA
- NYSE:QGEN -
NL0015002CX3
-
Common Stock
47.76
USD
+0.96 (+2.05%)
Last: 10/8/2025, 8:09:58 PM
47.6
USD
-0.16 (-0.34%)
Pre-Market:
10/9/2025, 8:12:06 AM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
QGEN Latest News, Press Relases and Analysis
All
Press Releases
7 days ago - By: Zacks Investment Research
- Mentions:
ILMN
TMO
MYGN
Illumina to Join Pharma Partners for CDx Development on KRAS Biomarker
8 days ago - By: Zacks Investment Research
- Mentions:
DGX
TMO
Quest Diagnostics Joins Forces With Epic to Improve Laboratory Testing
9 days ago - By: Zacks Investment Research
- Mentions:
TMO
ILMN
PACB
PacBio Enters Carrier Screening Market With PureTarget Expansion
9 days ago - By: Zacks Investment Research
- Mentions:
TMO
HOLX
QDEL
QuidelOrtho Expands Portfolio With the Launch of FDA-Approved Test
9 days ago - By: Zacks Investment Research
- Mentions:
DGX
EXAS
GH
DGX's Haystack Oncology Teams Up With Rutgers Cancer Institute
a month ago - By: QIAGEN N.V.
QIAGEN Secures European CE-IVDR Certification for Full QIAstat-Dx Portfolio
a month ago - By: Zacks Investment Research
- Mentions:
HOLX
BDX
Hologic's 2025 Outlook Improves on Strong Q3, Easing Tariff Headwinds
a month ago - By: Zacks Investment Research
- Mentions:
MASI
PAHC
NVST
QIAGEN Stock May Benefit From the US Clearance of QIAstat-Dx Rise
a month ago - By: QIAGEN N.V.
QIAGEN Gains U.S. Clearance of Higher-Throughput QIAstat-Dx Rise, Expanding Patient Access to Rapid Syndromic Testing
a month ago - By: Zacks Investment Research
- Mentions:
HOLX
BSX
The Role of M&A in Hologic's Growth Story: Are More Deals in Sight?
2 months ago - By: Zacks Investment Research
- Mentions:
NVS
INCY
INCY Stock Trading Close to Its 52-Week High: Buy, Sell or Hold?
2 months ago - By: Benzinga
- Mentions:
AFG
CXDO
YUM
PACK
...
Earnings Scheduled For August 5, 2025
2 months ago - By: Benzinga
A Look at Qiagen's Upcoming Earnings Report
4 months ago - By: Stocktwits
- Mentions:
INCY
ILMN
Retail Investors Flock To Incyte As Drug Data, Qiagen Deal Fuel Optimism
2 months ago - By: Zacks Investment Research
Why Qiagen (QGEN) International Revenue Trends Deserve Your Attention
2 months ago - By: Zacks Investment Research
Qiagen (QGEN) Reports Q2 Earnings: What Key Metrics Have to Say
2 months ago - By: Zacks Investment Research
- Mentions:
DTIL
Qiagen (QGEN) Matches Q2 Earnings Estimates
2 months ago - By: QIAGEN N.V.
QIAGEN exceeds outlook for Q2 2025 with solid growth and improved profitability
3 months ago - By: QIAGEN N.V.
QIAGEN Expands NGS Portfolio with Launch of QIAseq xHYB Long Read Panels
3 months ago - By: QIAGEN N.V.
QIAGEN N.V. to Release Results for Q2 2025 and Hold Webcast
3 months ago - By: QIAGEN N.V..
QIAGEN Announces Election of Stephen Rusckowski as Chairman of Supervisory Board
4 months ago - By: Yahoo Finance
- Mentions:
INCY
ILMN
VRNA
Incyte (INCY) Teams Up with QIAGEN to Boost Blood Cancer Diagnostic Solutions
4 months ago - By: Zacks Investment Research
Here's Why Qiagen (QGEN) is a Strong Growth Stock
4 months ago - By: QIAGEN N.V.
QIAGEN and GENCURIX Announce QIAcuity Digital PCR IVD Assay Development Partnership
4 months ago - By: Yahoo Finance
- Mentions:
GS
INCY
RY
RY.CA
...
Incyte (INCY) Targets $1B Growth by 2029 with New Drug Launches
4 months ago - By: QIAGEN N.V.
- Mentions:
INCY
QIAGEN and Incyte Announce Precision Medicine Collaboration to Develop Companion Diagnostics for Patients With Mutant CALR-expressing Myeloproliferative Neoplasms (MPNs)
4 months ago - By: Zacks Investment Research
- Mentions:
INCY
Qiagen (QGEN) Up 8.1% Since Last Earnings Report: Can It Continue?
4 months ago - By: Zacks Investment Research
- Mentions:
COR
PAHC
HIMS
QGEN Stock to Gain From Expanding Oncology Portfolio via New Alliances
4 months ago - By: Yahoo Finance
- Mentions:
VZ
ASC
KeyBank adopts Personetics platform to enhance client engagement
4 months ago - By: QIAGEN N.V.
QIAGEN expands portfolio for minimal residual disease (MRD) testing in oncology with new strategic partnerships
4 months ago - By: Foresight Diagnostics, Inc.
Foresight Diagnostics and QIAGEN Announce Strategic Partnership to Advance Development of Companion Diagnostic Kits for Lymphoma
5 months ago - By: Yahoo Finance
- Mentions:
MRNA
TGT
RIO
TSLA
Qiagen and ID Solutions Partner to Enhance Digital PCR Assays for Oncology Research
5 months ago - By: Zacks Investment Research
- Mentions:
ANGO
DXCM
STE
QGEN Stock Might Gain Following New Partnership With ID Solutions
5 months ago - By: QIAGEN N.V.
QIAGEN expands digital PCR oncology research portfolio through partnership with ID Solutions
Please enable JavaScript to continue using this application.